$0.15 0.00 (+0.40%)
11/24/2009 3:59 PM

Cortex Pharmaceuticals (COR)

CAPS Rating: No stars

The Company is engaged in the discovery, development and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Featured Broker Partners